Zhenhua Gao

Zhenhua Gao


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
TYTao Yang
Tao Yang
QZQingguo Zhao
Qingguo Zhao
MHMeijun Hu
Meijun Hu
SPSimin Pan
Simin Pan
LZLinying Zhang
Linying Zhang
ZSZhaochen Shan
Zhaochen Shan
Radiotherapy for head-and-neck cancers frequently causes long-term hypofunction of salivary glands that severely compromises quality of life and is difficult to treat. Here, we studied effects and mechanisms of Sphingosine-1-phosphate (S1P), a versatile signaling sphingolipid, in preventing irreversible dry mouth caused by radiotherapy. Mouse submandibular glands (SMGs) were irradiated with or without intra-SMG S1P pretreatment. The saliva flow rate was measured following pilocarpine stimulation. The expression of genes related to S1P signaling and radiation damage was examined by flow cytometry, immunohistochemistry, quantitative RT-PCR, Western blotting, and/or single-cell RNA-sequencing. S1P pretreatment ameliorated irradiation-induced salivary dysfunction in mice through a decrease in irradiation-induced oxidative stress and consequent apoptosis and cellular senescence, which is related to the enhancement of Nrf2-regulated anti-oxidative response. In mouse SMGs, endothelial cells and resident macrophages are the major cells capable of producing S1P and expressing the pro-regenerative S1P receptor S1pr1. Both mouse SMGs and human endothelial cells are protected from irradiation damage by S1P pretreatment, likely through the S1pr1/Akt/eNOS axis. Moreover, intra-SMG-injected S1P did not affect the growth and radiosensitivity of head-and-neck cancer in a mouse model. These data indicate that S1P signaling pathway is a promising target for alleviating irradiation-induced salivary gland hypofunction.

18 December 2024 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
YHYilin He
Yilin He
WSWenpeng Song
Wenpeng Song
YDYinxin Deng
Yinxin Deng
XLXiao Lin
Xiao Lin
ZGZhenhua Gao
Zhenhua Gao
PMPan Ma
Pan Ma

21 April 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
YSYuanyuan Shi
Yuanyuan Shi
YWYingxin Wang
Yingxin Wang
ZSZhaochen Shan
Zhaochen Shan
ZGZhenhua Gao
Zhenhua Gao
Introduction: Decellularized extracellular matrix has been recognized as an optimal scaffold for dental pulp regeneration. However, the limited amount of native dental pulp tissue restricts its clinical applications. The submandibular gland shares some basic extracellular matrix components and characteristics with dental pulp. However, whether decellularized submandibular gland extracellular matrix (DSMG) can be used as an alternative scaffold for dental pulp regenerative medicine is unclear.Methods: Thus, we successfully decellularized the whole rat submandibular gland and human dental pulp, and then conducted in vitro and in vivo studies to compare the properties of these two scaffolds for dental pulp regeneration.Results: Our results showed that extracellular matrix of the submandibular gland had great similarities in structure and composition with that of dental pulp. Furthermore, it was confirmed that the DSMG could support adhesion and proliferation of dental pulp stem cells in vitro. In vivo findings revealed that implanted cell-seeded DSMG formed a vascularized dental pulp-like tissue and expressed markers involved in dentinogenesis and angiogenesis.Discussion: In summary, we introduced a novel accessible biological scaffold and validated its effectiveness as an extracellular matrix-based tissue engineering scaffold for dental pulp regenerative therapy.

2 May 2024 in Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
YYYang Yang
Yang Yang
CZConghui Zhao
Conghui Zhao
ZYZi Yang
Zi Yang
CDConglin Du
Conglin Du
ZCZhichao Chang
Zhichao Chang
ZGZhenhua Gao
Zhenhua Gao
Inflammatory bowel disease (IBD) is characterized by inflammatory conditions in the gastrointestinal tract. According to reports, IBD prevalence is increasing globally, with heavy economic and physical burdens. Current IBD clinical treatment is limited to pharmacological methods; therefore, new strategies are needed. Myeloid-derived growth factor (MYDGF) secreted by bone marrow-derived mononuclear macrophages has beneficial effects in multiple inflammatory diseases. To this end, the present study aimed to establish an experimental IBD mouse model using dextran sulfate sodium in drinking water. MYDGF significantly alleviated DSS-induced colitis, suppressed lymphocyte infiltration, restored epithelial integrity in mice, and decreased apoptosis in the colon tissue. Moreover, the number of M1 macrophages was decreased and that of M2 macrophages was increased by the action of MYDGF. In MYDGF-treated mice, the NF-κB and MAPK pathways were partially inhibited. Our findings indicate that MYDGF could mitigate DSS-induced mice IBD by reducing inflammation and restoring epithelial integrity through regulation of intestinal macrophage polarization via NF-κB and MAPK pathway inhibition. Key messages: MYDGF alleviated DSS-induced acute colitis. MYDGF maintains colon epithelial barrier integrity and relieves inflammation. MYDGF regulates colon macrophage polarization. MYDGF partially inhibited the activation of NF-κB and MAPK pathway.

14 June 2025 in Experimental Cell Research
Verified
Journal Article
Closed access
YDYiping Dou
Yiping Dou
SYShujia Yu
Shujia Yu
SCShiyu Cao
Shiyu Cao
KGKang Gao
Kang Gao
MLMenghao Lv
Menghao Lv
PMPan Ma
Pan Ma

20 August 2023 in Archives of Oral Biology
Verified
Journal Article
Closed access
YWYingxin Wang
Yingxin Wang
YSYuanyuan Shi
Yuanyuan Shi
LWLingxiao Wang
Lingxiao Wang
JXJunji Xu
Junji Xu
ZSZhaochen Shan
Zhaochen Shan
ZGZhenhua Gao
Zhenhua Gao